Merrilees J

References (2)

Title : Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial - Boxer_2013_Lancet.Neurol_12_149
Author(s) : Boxer AL , Knopman DS , Kaufer DI , Grossman M , Onyike C , Graf-Radford N , Mendez M , Kerwin D , Lerner A , Wu CK , Koestler M , Shapira J , Sullivan K , Klepac K , Lipowski K , Ullah J , Fields S , Kramer JH , Merrilees J , Neuhaus J , Mesulam MM , Miller BL
Ref : Lancet Neurol , 12 :149 , 2013
Abstract : Boxer_2013_Lancet.Neurol_12_149
ESTHER : Boxer_2013_Lancet.Neurol_12_149
PubMedSearch : Boxer_2013_Lancet.Neurol_12_149
PubMedID: 23290598

Title : An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration - Boxer_2009_Alzheimer.Dis.Assoc.Disord_23_211
Author(s) : Boxer AL , Lipton AM , Womack K , Merrilees J , Neuhaus J , Pavlic D , Gandhi A , Red D , Martin-Cook K , Svetlik D , Miller BL
Ref : Alzheimer Disease & Associated Disorders , 23 :211 , 2009
Abstract : Boxer_2009_Alzheimer.Dis.Assoc.Disord_23_211
ESTHER : Boxer_2009_Alzheimer.Dis.Assoc.Disord_23_211
PubMedSearch : Boxer_2009_Alzheimer.Dis.Assoc.Disord_23_211
PubMedID: 19812461